S&P 500 7,513.48 +0.94% NASDAQ 25,872.07 +1.43% DOW 52,334.21 +0.95% R2K 2,981.58 +1.33% VIX 17.07 -8.47% US 10Y 4.63 +0.61% DXY 101.11 +0.12% GOLD 4,075.50 +1.63% CRUDE 84.38 +1.38% BITCOIN 66,477.86 +1.91%
Next Bullish Trade
Sign in
NTRA

Natera, Inc. NTRA

$264.44 +1.81 (+0.69%)
Neutral · +0.14σ
+ Compare Open in Sniper

Price chart

Timeframe
Range
Fundamentals · free Click ▲ earnings markers (daily) for the day's move

Loading…

Latest bar · NTRA

Momentum reads · latest daily bar
Last
$264.44
+1.81 (+0.69%)
Mkt cap
$37.9B
Healthcare
RSI(14)
54.6
neutral
Stochastic %K
22.6
neutral
MFI(14)
48.4
neutral
ADX(14)
28.3
trending

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 $0.7B $-0.1B $-0.1B $0.0B -12.2% -13.4%
2025-12-31 $0.7B $0.0B $-0.0B $0.0B 7.1% -3.4%
2025-09-30 $0.6B $-0.1B $-0.1B $0.0B -14.8% -16.5%
2025-06-30 $0.5B $-0.1B $-0.1B $0.0B -18.5% -20.2%
2025-03-31 $0.5B $-0.1B $-0.1B $0.0B -13.3% -15.8%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare NTRA vs peers

Line NTRA up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing NTRA no peers yet — add up to 4 below
Sector peers + LLY + UNH + JNJ + MRK + ABBV + PFE
Popular + AAPL + MSFT + NVDA + AMZN + GOOG + META + TSLA + AVGO
Matchups NVDA · AMD · AVGO · SMCI · MU AAPL · MSFT · GOOG · META · AMZN JPM · GS · MS · BAC · C TSLA · RIVN · LCID · GM · F XOM · CVX · OXY · COP

Add tickers to compare with NTRA

~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.

Earnings replay · last 20 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

DateEPS actual EPS estSurprise Next-day
2026-05-07 -0.60 -0.55 -8.5% -11.6%
2026-02-26 0.36 -0.53 +167.5% -3.7%
2025-11-06 -0.64 -0.35 -80.7% +0.6%
2025-08-07 -0.74 -0.59 -24.5% +7.7%
2025-05-08 -0.50 -0.66 +24.2% -6.5%
2025-02-27 -0.41 -0.35 -18.3% -0.7%
2024-11-12 -0.26 -0.59 +56.2% +19.1%
2024-08-08 -0.30 -0.68 +56.1% +6.4%
2024-05-10 -0.56 -0.75 +25.8% -1.9%
2024-02-28 -0.64 -0.71 +10.0% +13.0%
2023-11-08 -0.95 -0.97 +1.9% +9.8%
2023-08-03 -0.97 -1.10 +12.1% +17.6%
2023-05-09 -1.23 -1.16 -6.0% -3.4%
2023-02-28 -1.37 -1.46 +6.2% +11.8%
2022-11-08 -1.25 -1.44 +13.2% -12.7%
2022-08-04 -1.50 -1.50 -0.1% +0.9%
2022-05-05 -1.45 -1.52 +4.4% +5.8%
2022-02-24 -1.49 -1.31 -13.3% +2.6%
2021-11-04 -1.63 -1.33 -22.9% +4.8%
2021-08-05 -1.32 -1.20 -9.6% -2.0%

Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
NTRA ★ $38B — -1291.9 15.1 -137.4 21.3 65.1% 38.8% — 0.36%
LLY $1,034B 41.2 25.8 — 29.3 33.2 82.8% 55.5% 169.9% 0.89%
UNH $395B 32.8 19.4 0.9 17.5 3.8 19.5% 0.4% 61.5% 5.76%
JNJ $600B 29.0 19.4 6.1 18.1 7.4 68.1% 6.6% -1.0% —
MRK $310B 35.3 13.0 — 11.9 6.8 76.7% 4.9% — 4.53%
ABBV $451B 124.6 15.7 7.2 17.1 -67.8 72.0% 12.4% -46.2% 4.61%
PFE $142B 19.0 8.8 — 7.6 1.6 74.8% 5.4% -10.1% 8.74%
TMO $192B 28.4 19.0 — 20.9 3.7 40.9% 6.2% 11.3% 2.87%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 45.5%

HolderShares% out
JPMORGAN CHASE & CO 13,386,667 9.35%
Price (T.Rowe) Associates Inc 12,184,876 8.51%
Blackrock Inc. 10,677,338 7.46%
Vanguard Capital Management LLC 6,008,496 4.20%
Vanguard Portfolio Management LLC 5,644,695 3.94%
Wellington Management Group, LLP 4,768,593 3.33%
State Street Corporation 3,417,472 2.39%
Farallon Capital Management LLC 3,207,366 2.24%
Duquesne Family Office Llc 3,063,606 2.14%
Geode Capital Management, LLC 2,775,928 1.94%

Insider activity · 90d

0 buys / 15 sells · ratio 0.0 · Finnhub

  • Rabinowitz Matthew SELL 4,000 @ $280.00
  • Moshkevich Solomon SELL 134,643 @ $274.06
  • Moshkevich Solomon SELL 134,943 @ $272.99
  • Moshkevich Solomon SELL 137,543 @ $267.19
  • RABINOWITZ DANIEL SELL 172,294 @ $278.77
  • RABINOWITZ DANIEL SELL 172,594 @ $278.25
  • RABINOWITZ DANIEL SELL 174,549 @ $277.29
  • RABINOWITZ DANIEL SELL 176,594 @ $276.24
  • RABINOWITZ DANIEL SELL 177,994 @ $275.20
  • RABINOWITZ DANIEL SELL 179,094 @ $274.19

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low
$193.0
Mean
$282.14285
High
$330.0
Analysts
21
Recommendation distribution · period 2026-07-01
12
14
4
Revision trend (2026-04-01 → 2026-07-01): net 25 → 26 +1 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

FormFiled DescriptionAction
4 2026-07-17 Insider transaction (Form 4) view ·
4 2026-07-17 Insider transaction (Form 4) view ·
4 2026-07-15 Insider transaction (Form 4) view ·
4 2026-07-08 Insider transaction (Form 4) view ·
4 2026-07-06 Insider transaction (Form 4) view ·
4 2026-07-06 Insider transaction (Form 4) view ·
8-K 2026-07-06 8-K view ·
4 2026-06-30 Insider transaction (Form 4) view ·
4 2026-06-30 Insider transaction (Form 4) view ·
4 2026-06-30 Insider transaction (Form 4) view ·
4 2026-06-30 Insider transaction (Form 4) view ·
4 2026-06-30 Insider transaction (Form 4) view ·
4 2026-06-30 Insider transaction (Form 4) view ·
4 2026-06-30 Insider transaction (Form 4) view ·
4 2026-06-30 Insider transaction (Form 4) view ·
4 2026-06-26 Insider transaction (Form 4) view ·
4 2026-06-26 Insider transaction (Form 4) view ·
4 2026-06-22 Insider transaction (Form 4) view ·
4 2026-06-17 Insider transaction (Form 4) view ·
4 2026-06-17 Insider transaction (Form 4) view ·
4 2026-06-16 Insider transaction (Form 4) view ·
8-K 2026-06-16 8-K view ·
4 2026-06-09 Insider transaction (Form 4) view ·
4 2026-06-05 Insider transaction (Form 4) view ·
8-K 2026-06-05 8-K view ·
4 2026-06-03 Insider transaction (Form 4) view ·
4 2026-06-03 Insider transaction (Form 4) view ·
4 2026-06-03 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-28 Insider transaction (Form 4) view ·
4 2026-05-28 Insider transaction (Form 4) view ·
4 2026-05-15 Insider transaction (Form 4) view ·
10-Q 2026-05-08 10-Q view ·
8-K 2026-05-07 8-K view ·
4 2026-05-06 Insider transaction (Form 4) view ·
4 2026-05-05 Insider transaction (Form 4) view ·
4 2026-05-05 Insider transaction (Form 4) view ·
4 2026-05-05 Insider transaction (Form 4) view ·
4 2026-05-05 Insider transaction (Form 4) view ·
4 2026-05-05 Insider transaction (Form 4) view ·
4 2026-05-05 Insider transaction (Form 4) view ·
4 2026-04-29 Insider transaction (Form 4) view ·
4 2026-04-29 Insider transaction (Form 4) view ·
4 2026-04-29 Insider transaction (Form 4) view ·
4 2026-04-29 Insider transaction (Form 4) view ·
4 2026-04-29 Insider transaction (Form 4) view ·
4 2026-04-29 Insider transaction (Form 4) view ·
4 2026-04-28 Insider transaction (Form 4) view ·
4 2026-04-28 Insider transaction (Form 4) view ·
4 2026-04-28 Insider transaction (Form 4) view ·
4 2026-04-28 Insider transaction (Form 4) view ·
4 2026-04-28 Insider transaction (Form 4) view ·
4 2026-04-28 Insider transaction (Form 4) view ·
4 2026-04-28 Insider transaction (Form 4) view ·
4 2026-04-28 Insider transaction (Form 4) view ·
DEF 14A 2026-04-23 DEF 14A view ·
4 2026-04-21 Insider transaction (Form 4) view ·
4 2026-04-08 Insider transaction (Form 4) view ·
4 2026-04-03 Insider transaction (Form 4) view ·
4 2026-04-03 Insider transaction (Form 4) view ·
4 2026-04-01 Insider transaction (Form 4) view ·

About NTRA

Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test. The company also provides Panorama, a non-invasive prenatal test; Horizon, a carrier screening test; Fetal Focus, a single-gene NIPT, or sgNIPT, that screens for 21 single-gene inherited conditions; and Vistara, a single-gene NIPT, which screens for 25 single-gene conditions. In addition, it offers Anora, which tests and analyzes miscarriage tissue from women who have experienced one or more pregnancy losses; Empower, a hereditary cancer screening test; Prospera, a test to assess active rejection in patients who have undergone solid organ transplantation; Renasight, a kidney gene panel test; and Constellation software, a cloud-based distribution model. Further, the company provides NateraCore, a platform to suppo…

Options picks · NTRA

ITM + OTM ideas from the latest scan

Loading…

Congress trades · NTRA

STOCK Act disclosures

Loading…

SEC filings & insiders · NTRA

EDGAR · live

Loading…

Holders · NTRA

Institutions & insider activity

Loading…